SCHEMBL644106

SCHEMBL644106

COC(=O)Cc1ccccc1N(C)S(=O)(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
ALPL P05186 1/20 0.48
ALPI P09923 1/20 0.48
ALPG P10696 1/20 0.48
KCNJ6 P48051 1/20 0.44
KCNJ5 P48544 1/20 0.44
KCNJ3 P48549 1/20 0.44
POLB P06746 2/20 0.43
RAB9A P51151 1/20 0.43
MAPT P10636 3/20 0.42
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 2/20 0.42
ACLY P53396 1/20 0.42
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MCOLN3 Q8TDD5 1/20 0.42
MEN1 O00255 2/20 0.41
ADRB2 P07550 1/20 0.41
RECQL P46063 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033827 0.89 KMT2A (0.46) KMT2AALPLALPIALPGKCNJ6
SCHEMBL645178 0.87 KMT2A (0.46) KMT2AALPLALPIALPGKCNJ6
SCHEMBL14033416 0.80 KMT2A (0.44) KMT2AALPLALPIALPGKCNJ6
SCHEMBL643844 0.80 KMT2A (0.59) KMT2AALPLALPIALPGPOLB
SCHEMBL644961 0.76 ACLY (0.56) KMT2AALDH1A1ACLYLMNAMEN1
SCHEMBL645509 0.75 TDP1 (0.58) KMT2AALPLALPIALPGPOLB
SCHEMBL14033453 0.75 KMT2A (0.46) KMT2AALPLALPIALPGPOLB
SCHEMBL493681 0.74 KMT2A (0.50) KMT2AALPLALPIALPGPOLB
SCHEMBL6639953 0.72 KDM4E (0.44) KMT2APOLBMAPTALDH1A1KDM4E
SCHEMBL5278957 0.70 OPRK1 (0.46) KMT2ARAB9AALDH1A1KDM4EACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119633-B2 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed
US-20080312231-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312231-A1 Substituted Sulfonamide Compounds SULT2A1, SULT1A1, SCN1A KMT2A 2577/4885ALPL 3092/4885ALPI 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.